 | Fiscal NoteH.B. 99 2026 General Session Eyewear Sales Tax Amendments by Maloy, A. Cory |  |
| Ongoing | One-time | Total | |
|---|---|---|---|
| Net GF/ITF/USF (rev.-exp.) | $(7,500,000) | $800,000 | $(6,700,000) |
| Revenues | FY2026 | FY2027 | FY2028 |
| Transportation Investment Fund of 2005 | $0 | $(2,925,000) | $(2,925,000) |
| Transportation Investment Fund of 2005, One-time | $0 | $300,000 | $0 |
| Other Financing Sources | $0 | $(975,000) | $(975,000) |
| Other Financing Sources, One-time | $0 | $100,000 | $0 |
| General Fund | $0 | $(7,500,000) | $(7,500,000) |
| General Fund, One-time | $0 | $800,000 | $0 |
| Total Revenues | $0 | $(10,200,000) | $(11,400,000) |
The expansion of the prosthetic device sales tax exemption to include prescribed corrective eyeglasses and contact lenses in this bill is estimated to reduce state sales tax revenues to the General Fund and earmarks by approximately $10.2 million in FY 2027 and $11.4 million in FY 2028.
| Expenditures | FY2026 | FY2027 | FY2028 |
| Total Expenditures | $0 | $0 | $0 |
Enactment of this legislation likely will not materially impact state expenditures.
| FY2026 | FY2027 | FY2028 | |
| Net All Funds (rev-exp) | $0 | $(10,200,000) | $(11,400,000) |
The expansion of the prosthetic device sales tax exemption to include prescribed corrective eyeglasses and contact lenses in this bill is estimated to reduce local sales tax revenues by approximately $5.4 million in FY 2027 and $6.0 million in FY 2028.
The expansion of the prosthetic device sales tax exemption to include prescribed corrective eyeglasses and contact lenses in this bill is estimated to reduce sales tax liability for purchasers of these products by approximately $15.6 million in FY 2027 and $17.4 million in FY 2028.
Enactment of this legislation likely will not change the regulatory burden for Utah residents or businesses.
This bill does not create a new program or significantly expand an existing program.